European Archives - Page 140 of 996 - European Medical Journal

Computational Algorithm Enhances Patch Testing for Contact Dermatitis

Optimising formaldehyde-related allergen selection in patch testing for allergic contact dermatitis reduces costs while maintaining high capture rates.

Picture-Based Scorecard Improves Atopic Dermatitis Diagnosis Across Skin Tones

Recent study highlighted significant improvements in diagnosing atopic dermatitis among infants with diverse skin tones, with the use of picture-based scorecards.

Increased Risk of Psoriasis Linked to Formula Milk

Study found that infants introduced to formula before the age of four months had an increased risk of developing psoriasis.

Patient Blood Management and Haemovigilance: Pillars of Safe Blood Transfusion

One-fourth of the global population is anaemic, and as the population is gradually increasing day by day, so does the number of anaemia…

Consuming Peanuts During Infancy Prevents Allergy Development

Consistent peanut consumption, starting in infancy and continuing to 5 years of age, provides a lasting tolerance to peanuts which continues into early adolescence.

Higher Prevalence of Cirrhosis Amongst Transgender Adults

Transgender adults have been found to suffer from cirrhosis twice as often as cisgender individuals, in a recent study.

Early Detection of Aggressive Multiple Myeloma Through Molecular Analysis

New research on multiple myeloma provides a comprehensive proteogenomic analysis, revealing novel prognostic markers and potential therapeutic targets.

Associations Found between Diabetes and Liver Cancer

New research has revealed a link between diabetes and liver cancer, particularly in patients aged 40-54.

Researchers Discover a Neural Biomarker for OCD

A neural activity pattern has been identified that can accurately predict the clinical state of patients with obsessive-compulsive disorder.

New AI Model Predicts Disease Progression in Early Alzheimer’s Disease

A Predictive Prognostic Model has been developed to predict the rate at which individuals will progress to Alzheimer’s Disease.